Smiling woman sitting in front of green wall at AlkermesSmiling woman sitting in front of green wall at AlkermesBlue Triangle graphic

News and Events

Sharing Stories of
Patients, Employees
and Communities

Featured News

November 30, 2022

Alkermes to Participate in the BofA Securities 2022 Biotech SMID Cap Conference

Read more

November 22, 2022

Alkermes to Participate in the 5th Annual Evercore ISI HealthCONx Conference

Read more

November 08, 2022

Alkermes to Participate in the Stifel Healthcare Conference

Read more

See all press releases

Our Commitment to Responsibility

Corporate responsibility has always played a central role in our business and has proven even more critical during the past year as we faced some of the most pressing public health and societal issues of our time – a dynamic global pandemic, systemic racism in the U.S. and around the world, and a worsening climate change crisis. Guided by our purpose and values, we took actions to respond to these critical issues, while sharpening our focus on scientific and business excellence in our efforts to help people living with complex and difficult-to-treat diseases. Our most recent Corporate Responsibility Report expounds on these efforts.

Corporate Responsibility reports   

Our Stories

Each endeavor at Alkermes starts with collaboration and our shared commitment to make a difference for patients and our communitiesThese stories – which highlight our people, science and innovation, and leadership perspectives – showcase just a subset of what makes us proud to be part of Alkermes. Visit our full gallery of stories by clicking on the link below.

Harris Poll logo on white background

Psychiatrist Perspectives

Alkermes worked with The Harris Poll to gather psychiatrists’ insights and perspectives on caring for people living with bipolar I disorder.

Learn about the survey

HBA Luminary 2022

Congratulations to Kanchan Relwani, M.D., Head of Medical Affairs, for being recognized as our 2022 Healthcare Businesswomen’s Association Luminary – a testament to her role as a mentor and leader.

Learn more

Headshot of Kanchan Relwani

Portrait of employee standing in lab

Cancer Trials At-a-Glance

Learn more about our ongoing clinical development program for nemvaleukin alfa, our lead immuno-oncology candidate.

View Infographic

Media Resources

Company Description

Alkermes is focused on developing innovative medicines that seek to address unmet needs of people living with serious mental illness, addiction and cancer. As a fully-integrated, global biopharmaceutical company, with U.S. locations in Massachusetts and Ohio, and locations in Dublin and Athlone, Ireland, we apply our scientific expertise and proprietary technologies to develop products designed to make a meaningful difference in the way people manage their diseases. Beyond our scientific pursuits, we also work to help support and enhance the systems through which these complex diseases are treated. We are committed to patient engagement, disease education and supporting policies that enable access to approved treatment options.

Media Inquiries

Email our media team

Company Logos


Company Photo


Corporate Fact Sheet


Follow us on our social channels   

blue triangle graphic

Statements and Positions

The idea that a corporation can play a profoundly positive role in society is central to our vision. It is our obligation to voice our beliefs about issues that impact the patients we serve, the communities in which we live and work and society at large.

Company Statement on the Invasion of Ukraine

Read our statement

Company Response to Board Nominations

Read our statement

Systemic Racism and Violence

Read our statement

Company Response to COVID-19

Read our response